🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Kapiva spends Rs 188 Cr on advertising in FY25; posts Rs 342 Cr revenue

EntrackrEntrackr · 27d ago
Kapiva spends Rs 188 Cr on advertising in FY25; posts Rs 342 Cr revenue
Medial

Kapiva sustained its strong growth momentum in the fiscal year ended March 31, 2025, as revenue rose nearly 50% year on year. However, higher incremental spending during the year weighed on the bottom line and led to a 23% increase in the company’s losses over the same period. Kapiva’s revenue from operations grew 50% to Rs 342 crore in FY25 from Rs 228 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). Founded in 2015, Kapiva is an ayurvedic nutrition brand offering natural and organic products in categories such as diabetes, hypertension, liver health, hormonal balance, wellness, energy, and sports nutrition. Sale of these products was the sole source of revenue for the company. Including non-operating income of Rs 7 crore, the company’s total income stood at Rs 349 crore in FY25. For the D2C brand, advertising and promotional expenditure remained the largest cost contributor, accounting for 45% of the total expense. This cost rose 53% to Rs 188 crore in FY25 from Rs 123 crore in FY24. Cost of materials consumed grew 43% to Rs 97 crore, contributing about 23% of overall costs, while employee benefit expenses increased 28% to Rs 59 crore. Transportation cost stood at Rs 22 crore, legal charges doubled to Rs 16 crore, and other overheads added another Rs 36 crore during the year. Overall, the company’s total expense rose 44% to Rs 418 crore in FY25 from Rs 290 crore in FY24. Kapiva’s net loss rose 23% to Rs 69 crore in FY25 from Rs 56 crore in FY24. Its ROCE and EBITDA margin stood at -51.41% and -20.88% respectively. On a unit level, the company spent Rs 1.22 to earn a rupee, better than Rs 1.27 it spent in FY24. The company recorded cash and bank balances of Rs 139 crore, while its current assets were valued at Rs 199 crore in the same period.

Exclusive: Kapiva raises $10 Mn from existing investors

EntrackrEntrackr · 1y ago
Exclusive: Kapiva raises $10 Mn from existing investors
Medial

Homegrown D2C ayurvedic nutrition brand Kapiva has raised Rs 83.5 crore (approximately $10 million) led by OrbiMed Asia with the participation of 3One4 Capital and Vertex Ventures. The board at Kapiva has passed a special resolution to issue 5,62,631 compulsory convertible preference shares to raise the aforementioned sum, its regulatory filing sourced from the Registrar of Companies shows. OrbiMed Asia led the round with Rs 52.2 crore, while 3One4 Capital and Vertex Ventures participated with Rs 11.96 crore and Rs 19.33 crore, respectively. The fresh funding appears to be part of Kapiva’s Series C round, in which the firm is aiming to raise a total of Rs 250 crore. Entrackr exclusively reported about Kapiva’s Series C round in Nov 2022. With the fresh tranche, the firm has raised Rs 132 crore in the ongoing round. It had already raised Rs 48.75 crore ($6 million) in Series C from OrbiMed and other existing investors back in October 2022. Kapiva has also increased its ESOP size by adding 1,415,00 new employee stock, bringing the total ESOP pool to 4,47,741, separate filing shows. As per the Entrackr estimates, its ESOP pool size is now worth Rs 66 crore. Kapiva will use these funds for the expansion and development of the company. Kaviva has raised over $30 million to date and has notable investors including Jetty Ventures, Fireside, OrbiMed, 3One4Capital, and others. According to the startup data intelligence platform TheKredible, the company has been valued at around $80 million post-allotment. Founded in 2015, Kapiva is an ayurvedic nutrition brand that offers natural and organic health and skincare products for hair fall, weight loss, digestion, diabetes in the form of juices, tea, oils, shakes et al. During the fiscal year ended March 2023, Kaviva registered 87% year-on-year growth to Rs 116.48 crore with a loss standing at Rs 64.5 crore in the same period. Kapiva is yet to file its annual results for FY24. While the D2C ayurveda space is crowded with plenty of organized brands, Upakarma Ayurveda, and Dr. Vaidya’s, Varalife, among others are Kapiva’s notable competitors.

Wellbeing Nutrition claims Rs 170 Cr revenue in FY25; retail share at 25%

EntrackrEntrackr · 5m ago
Wellbeing Nutrition claims Rs 170 Cr revenue in FY25; retail share at 25%
Medial

Clean-label nutraceutical brand Wellbeing Nutrition closed FY25 with revenue of about Rs 170 crore, posting over 100% year-on-year growth. Losses, however, widened to a little over Rs 30 crore, according to the company’s spokesperson. In Q1 FY26, the Avnish Chhabria-led firm clocked around Rs 80 crore in revenue. At the contribution margin (CM3) level, losses were about 2%, which the company expects to improve in the coming quarters. For FY26, Wellbeing Nutrition is targeting gross sales of Rs 350 crore while narrowing its losses by 20–30%. It projects revenue of Rs 600–650 crore in FY27 and aims to turn EBITDA-profitable by the end of the current fiscal year, as per its press release. Online channels, including its D2C platform, Amazon, Nykaa, and quick commerce partners, contribute around 70% of sales. Retail through pharmacies, modern trade, malls, and airports makes up 25%, while exports account for 5–10%. The brand is present in more than 3,700 retail stores in India and ships to over 25 international markets, including the US, UK, UAE, and Southeast Asia. According to startup data platform TheKredible, Wellbeing Nutrition has raised close to $14 million to date, including a $10 million Series B round led by Fireside Ventures and Hindustan Unilever (HUL) in December 2022. Founded in 2019, the company has expanded its portfolio across categories such as sleep, immunity, beauty, and stress. It plans to roll out 20–25 new products in FY26 in emerging segments like kids’ nutrition and gut health. Wellbeing Nutrition competes with Oziva, Kapiva, Gynoveda, and Nyumi in India’s growing nutraceutical and wellness market. With consistent triple-digit growth and a focus on scale, the company is positioning itself among a handful of consumer health brands chasing profitability at a larger scale.

Download the medial app to read full posts, comements and news.